Autopsy report · NCT07791992

Combination of High-flow Nasal Oxygen (Optiflow) and Vibrating Membrane Nebuliser (Aerogen) in the Pre-hospital Setting - Before/After Study

Cause of deathOther Automatic label, confidence 0.3, unverified. How labels are made.

“Le projet n'a pas obtenu l'autorisation réglementaire.”

The sponsor’s own words in the registry.

Life of this trial

Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status: Withdrawn
Sponsor: Centre Hospitalier Sud Francilien
Sponsor type: University, hospital or other
Conditions: Hypercapnia; Asthma Exacerbation; COPD Exacerbation
Interventions: Vibrating membrane nebulizer and high-intensity nasal oxygen; nebulizer mask and oxygen therapy of 6 to 9 liters per minute
Participants: 0
Sites: 1
Countries: France

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.